HALEON PLC
LSE:HLN
Operating Margin
HALEON PLC
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
|
HALEON PLC
LSE:HLN
|
34.7B GBP |
23%
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
195B EUR |
20%
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
112.9B GBP |
18%
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR |
21%
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.8B EUR |
16%
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27B USD |
9%
|
|
| JP |
|
Kao Corp
TSE:4452
|
3T JPY |
9%
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
19%
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
827.5B INR |
15%
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
-13%
|
|
| US |
|
Bellring Brands Inc
NYSE:BRBR
|
7.5B USD |
20%
|
HALEON PLC
Glance View
In the bustling world of consumer healthcare, HALEON PLC stands as a luminary figure, emerging with a focused mission: to deliver everyday health with humanity. Spun off from the pharmaceutical giant GlaxoSmithKline, HALEON now charts its independent course, concentrating on the development and distribution of over-the-counter medications, oral health products, and nutritional supplements. Its diverse portfolio includes household names such as Sensodyne, Panadol, and Centrum, demonstrating its wide-reaching impact on consumers’ health routines. These brands are not merely market fixtures; they represent HALEON’s commitment to blending scientific innovation with consumer insights, aiming to enhance well-being across the globe. HALEON’s business model is poised at the intersection of healthcare and retail, thriving through an intricate blend of strategic marketing, global distribution networks, and strong brand equity. By leveraging extensive consumer research data, HALEON aligns its product offerings with the evolving needs and preferences of its audience. The company generates revenue primarily through product sales, employing an omnichannel strategy that ensures product availability across various retail and digital platforms. Its strategic alliances and network with pharmacies, supermarkets, and online marketplaces cement its accessibility and prominence in the market. Additionally, HALEON's stream of revenue is bolstered by its investment in innovation—a key driver that keeps its product lines relevant and competitive in a dynamic healthcare landscape.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on HALEON PLC's most recent financial statements, the company has Operating Margin of 22.7%.
You don't have any saved screeners yet